Fas- and perforin-independent mechanism of cytotoxic T lymphocyte

Immunologic Research

Volumn 17, Issue 1-2, 1998, Pages 89-93

  Kajino, Kiichi ^a   Kajino, Yuri ^a   Greene, Mark I ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b 252 John Morgan Building ^*  (United States)

Author keywords

Cytotoxic T lymphocyte; Death domain; Fas; Fas ligand; Perforin

Indexed keywords

FAS LIGAND; PERFORIN;

APOPTOSIS; CELL MEMBRANE; CYTOTOXIC T LYMPHOCYTE; LYMPHOCYTE CLONE; PRIORITY JOURNAL; REVIEW; TARGET CELL;

EID: 0031916338     PISSN: 0257277X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02786434     Document Type: Review

References (44)

1. Zinkernagel RM, Doherty PC: MHC-restricted cytotoxic T cells: studies on the biological role of polymorphic major transplantation antigens determining T-cell restriction-specificity, function, and responsiveness. Adv Immunol 1979;27:51-177.
2. Berke G: The CTL's kiss of death. Cell 1995;81:9-12.
3. Henkart PA: Mechanism of lymphocyte-mediated cytotoxicity. Annu Rev Immunol 1985;3:31-58.
4. Tschopp J, NabholZ M: Perforin-mediated target cell lysis by cytolytic T lymphocytes. Annu Rev Immunol 1990;8:279-302.
5. Podack ER, Hengartner H, Lichtenheld MG: A central role of perforin in cytolysis? Annu Rev Immunol 1991;9:129-157.
6. Ostergaard HL, Kane KP, Mescher MF, Clark WR: Cytotoxic T lymphocyte mediated lysis without release of serine esterase. Nature 1987;330:71-72.
7. Trenn G, Takayama H, Sitkovsky MV: Exocytosis of cytolytic granules may not be required for target cell lysis by cytotoxic T-lymphocytes. Nature 1987;330:72-74.
8. Berke G, Rosen D, Ronen D: Mechanism of lymphocyte-mediated cytolysis: functional cytolytic T-cells lacking perform and granzymes. Immunology 1993; 78:105-112.
9. Strack P, Martin C, Saito S, Dekruyff RH, Ju ST: Metabolic-inhibitors distinguish cytolytic activity of CD4 and CD8 clones. Eur J Immunol 1990;20:179-184.
10. Takayama H, Shinohara N, Kawasaki A, Someya Y, Hanaoka S, Kojima H, et al.: Antigen-specific directional target cell lysis by perforin-negative T lymphocyte clones. Int Immunol 1991;3:1149-1156.
11. Lancki DW, Hsieh CS, Fitch FW: Mechanisms of lysis by cytotoxic T-lymphocyte clones. Lytic activity and gene expression in cloned antigen-specific CD4+ and CD8+ T lymphocytes. J Immunol 1991;146:3242-3249.
12. Kägi D, Vignaux F, Ledermann B, Burki K, Depraetere V, Nagata S, et al.: Fas and perform pathways as major mechanisms of T-cell-mediated cytotoxicity. Science 1994;265: 528-530.
13. Kojima H, Shinohara N, Hanaoka S, Someya-Shirota Y, Takagaki Y, Ohno H, et al.: Two distinct pathways of specific killing revealed by perforin mutant cytotoxic T lymphocytes. Immunity 1994;1:357-364.
14. Lowin B, Hahne M, Mattmann C, Tschopp J: Cytolytic T-cell cytotoxicity is mediated through perforin and Fas lytic pathways. Nature 1994;370:650-652.
15. Walsh CM, Matloubian M, Liu CC, Ueda R, Kurahara CG, Christensen JL, et al.: Immune function in mice lacking the perforin gene. Proc Natl Acad Sci USA 1994;91:10,854-10,858.
16. Rouvier E, Luciani MF, Golstein P: Fas involvement in Ca(2+)-independent T-cell-mediated cytotoxicity. J Exp Med 1993;177:195-200.
17. Stalder T, Hahn S, Erb P: Fas antigen is the major target molecule for CD4+ T-cell-mediated cytotoxicity. J Immunol 1994;152:1127-1133.
18. Yonehara S, Ishii A, Yonehara M: A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor. J Exp Med 1989;169:1747-1756.
19. Trauth BC, Klas C, Peters AM, Matzku S, Moller P, Falk W, et al.: Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science 1989;245:301-305.
20. Itoh N, Yonehara S, Ishii A, Yonehara M, Mizushima S, Sameshima M, et al.: The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 1991;66:233-243.
21. Watanabe-Fukunaga R, Brannan CI, Itoh N, Yonehara S, Copeland NG, Jenkins NA, et al.: The cDNA structure, expression, and chromosomal assignment of the mouse Fas antigen. J Immunol 1992;148:1274-1279.
22. Nagata S: Fas and Fas ligand: a death factor and its receptor. Adv Immunol 1994;57:129-144.
23. Suda T, Nagata S: Purification and characterization of the Fas-ligand that induces apoptosis. J Exp Med 1994;179:873-879.
24. Suda T, Takahashi T, Golstein P, Nagata S: Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 1993;75:1169-1178.
25. Cohen PL, Eisenberg RA: Lpr and gld: single gene models of systemic autoimmunity and lympho-proliferative disease. Annu Rev Immunol 1991;9:243-269.
26. Sobel ES, Kakkanaiah VN, Cohen PL, Eisenberg RA: Correction of gld autoimmunity by co-infusion of normal bone marrow suggests that gld is a mutation of the Fas ligand gene. Int Immunol 1993;5:1275-1278.
27. Ettinger R, Wang JK, Bossu P, Papas K, Sidman CL Abbas AK, et al.: Functional distinctions between MRL-lpr and MRL-gld lymphocytes. Normal cells reverse the gld but not lpr immunoregulatory defect. J Immunol 1994;152:1557-1568.
28. MacDonald GC, Kakkanaiah VN, Sobel ES, Cohen PL, Eisenberg RA: In vivo depletion of Thy-1-positive cells originating from normal bone marrow abrogates the suppression of gld disease in normal-gld mixed bone marrow chimeras. J Immunol 1995;154:444-449.
29. Nagata S, Suda T: Fas and Fas ligand: lpr and gld mutations. Immunol Today 1995;16:39-43.
30. Hashimoto Y, Maxam AM, Greene MIT-cell antigen-receptor genes in autoimmune mice. Proc Natl Acad Sci USA 1986;83:7865-7869.
31. Hashimoto Y, Yui K, Littman D, Greene MI: T-cell receptor genes in autoimmune mice: T-cell subsets have unexpected T-cell receptor gene programs. Proc Natl Acad Sci USA 1987;84:5883-5887.
32. Wadsworth S, Yui K, Siegel RM, Tenenholz DE, Hirsch JA, Greene MI: Origin and selection of peripheral CD4-CD8- T-cells bearing alpha/beta T-cell antigen receptors in autoimmune gld mice. Eur J Immunol 1990;20:723-730.
33. Yui K, Wadsworth S, Yellen A, Hashimoto Y, Kokai Y, Greene MI: Molecular and functional properties of novel T-cell subsets in C3H-gld/gld and nude mice. Implications for thymic and extra-thymic maturation. Immunol Rev 1988;104:121-155.
34. Yui K, Hashimoto Y, Wadsworth S, Greene MI: Characterization of Lyt-2-, L3T4- class I-specific cytolytic clones in C3H-gld/gld mice. Implications for functions of accessory molecules and programmed development. J Exp Med 1987;166:1026-1040.
35. Wadsworth S, Yui K, Greene MI: Major histocompatibility complex class I-specific cytolytic T-cells, derived from gld mice, lacking Thy-1, CD4, and CD8. Proc Natl Acad Sci USA 1989;86:1018-1022.
36. Yui K, Hashimoto Y, Greene MI: T-cell receptors of autoimmune mice: functional and molecular analysis of novel T-cell subsets in C3H-gld/gld mice. Immunol Res 1988;7:173-188.
37. Braun MY, Lowin B, French L, Acha-Orbea H, Tschopp J: Cytotoxic T-cells deficient in both functional fas ligand and perforin show residual cytolytic activity yet lose their capacity to induce lethal acute graft-versus-host disease. J Exp Med 1996;183:657-661.
38. Kataoka T, Shinohara N, Takayama H, Takaku K, Kondo S, Yonehara S, et al.: Concanamycin A, a powerful tool for characterization and estimation of contribution of perforin- and Fas-based lytic pathways in cell-mediated cytotoxicity. J Immunol 1996;156:3678-3686.
39. Tartaglia LA, Ayres TM, Wong GH, Goeddel DV: A novel domain within the 55kd TNF receptor signals cell death. Cell 1993;74:845-853.
40. Zhou T, Edwards CK 3rd, Yang P, Wang Z, Bluethmann H, Mountz JD: Greatly accelerated lymphadenopathy and autoimmune disease in lpr mice lacking tumor necrosis factor receptor I. J Immunol 1996; 156:2661-2665.
41. Kitson J, Raven T, Jiang YP, Goeddel DV, Giles KM, Pun KT, et al.: A death-domain-containing receptor that mediates apoptosis. Nature 1996;384:372-375.
42. Chinnaiyan AM, O'Rourke K, Yu GL, Lyons RH, Garg M, Duan DR, et al.: Signal transduction by DR3, a death domain-containing receptor related to TNFR-1 and CD95. Science 1996;274:990-992.
43. Pan G, O'Rourke K, Chinnaiyan AM, Gentz R, Ebner R, Ni J, et al.: The receptor for the cytotoxic ligand TRAIL. Science 1997;276:111-113.
44. Bodmer JL, Burns K, Schneider P, Hofmann K, Steiner V, Thome M, B et al.: TRAMP, a novel apoptosis-mediating receptor with sequence homology to tumor necrosis factor receptor 1 and Fas(Apo-1/CD95). Immunity 1997;6:79-88.